Digging into a decades-old hepatitis B mystery suggests a new potential treatment
In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...
News Medical on MSN8h
Breakthrough discovery unveils potential treatment for hepatitis B
In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center ...
GEN3h
HBV’s Ability to Infect Human Liver Cells Thwarted by Potential Anticancer Drug
Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat chronic infections for the first time.
Dynavax projects HEPLISAV-B revenue of $305M-$325M for 2025 amid expanding hepatitis B market
Q4 2024 Management View CEO Ryan Spencer highlighted the company’s record HEPLISAV-B product revenue in Q4 and 2024, achieving profitability and implementing a share repurchase plan. Looking ahead, ...